Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
November 18 2020 - 4:41PM
Edgar (US Regulatory)
Filed by Akers Biosciences, Inc.
Pursuant to Rule 425 of the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company: MyMD Pharmaceuticals, Inc.
Commission File No.: 001-36268
Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Aug 2024 to Sep 2024
Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Sep 2023 to Sep 2024